Biotech & AI drug discoveryNature Medicine

Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial

A phase 1 trial of personalized neoantigen-targeting cancer vaccines in ovarian cancer was published in Nature Medicine. The supplied context does not include trial results or efficacy data.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-14T00:00:00+00:00

Published here2026-10-15T02:34:02+00:00

Original source

Nature Medicine

Media report · consult original reporting

Read the original ↗https://www.nature.com/articles/s41591-026-04717-8

Original headline

Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.